Literature DB >> 10526247

Population based study on serum ionised calcium, serum parathyroid hormone, and blood pressure. The Tromsø study.

R Jorde1, K H Bonaa, J Sundsfjord.   

Abstract

OBJECTIVE: To study associations between serum ionised calcium, serum parathyroid hormone (PTH) and blood pressure.
DESIGN: A population based, cross-sectional study was used.
METHODS: Blood pressure, body mass index, serum ionised calcium and serum PTH were measured in 460 males and 486 females in the Tromso study in 1994/1995. None were on medication for hypertension. The data were analysed with a multiple linear regression model.
RESULTS: When looking at subjects with serum ionised calcium<1.39mmol/l, there was a significant negative association (P<0.01) between serum ionised calcium and PTH. There was no association between blood pressure and serum ionised calcium. In both sexes there was a significant positive association between age and serum PTH (P<0.01). For women, but not for men, there was a significant positive association between serum PTH and systolic and diastolic blood pressure (P<0.01). Within each age group there was a difference in both systolic and diastolic blood pressure of 3-10mmHg between the upper and lower serum PTH halves of the female population. Females with hypertension had significantly higher serum PTH levels than the normotensive females (P<0.01).
CONCLUSION: Serum PTH is strongly and positively associated with blood pressure in women.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526247     DOI: 10.1530/eje.0.1410350

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  15 in total

1.  Causes of secondary hyperparathyroidism in a healthy population: the Tromsø study.

Authors:  Farahnaz Saleh; Rolf Jorde; Johan Sundsfjord; Egil Haug; Yngve Figenschau
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  The relationship between blood pressure and serum parathyroid hormone with special reference to urinary calcium excretion: the Tromsø study.

Authors:  F Saleh; R Jorde; J Svartberg; J Sundsfjord
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

3.  Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects.

Authors:  L Maïmoun; D Simar; D Malatesta; C Caillaud; E Peruchon; I Couret; M Rossi; D Mariano-Goulart
Journal:  Br J Sports Med       Date:  2005-08       Impact factor: 13.800

4.  Myocardial perfusion defects and the left ventricular ejection fraction disclosed by scintigraphy in patients with primary hyperparathyroidism.

Authors:  Christina Gerlach Ogard; Susanne Bonnichsen Søndergaard; Henrik Vestergaard; Henrik Jakobsen; Steen Levin Nielsen
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study.

Authors:  Rolf Jorde; Knut Waterloo; Farahnaz Saleh; Egil Haug; Johan Svartberg
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

6.  Prediagnostic circulating parathyroid hormone concentration and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.

Authors:  Veronika Fedirko; Elio Riboli; H Bas Bueno-de-Mesquita; Sabina Rinaldi; Tobias Pischon; Teresa Norat; Eugène H J M Jansen; Fränzel J B van Duijnhoven; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Pierre Engel; Rudolf Kaaks; Birgit Teucher; Heiner Boeing; Brian Buijsse; Antonia Trichopoulou; Dimitrios Trichopoulos; Pagona Lagiou; Sabina Sieri; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Carla H van Gils; Petra H M Peeters; Maria-Dolores Chirlaque; Aurelio Barricarte Gurrea; Laudina Rodríguez; Esther Molina-Montes; Miren Dorronsoro; Catalina Bonet; Richard Palmqvist; Göran Hallmans; Timothy J Key; Konstantinos K Tsilidis; Kay-Tee Khaw; Isabelle Romieu; Kurt Straif; Petra A Wark; Dora Romaguera; Mazda Jenab
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-04       Impact factor: 4.254

7.  Effect of calcium supplementation on blood pressure in patients with secondary hyperparathyroidism.

Authors:  F Saleh; R Jorde; J Sundsfjord
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

8.  The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis.

Authors:  Maryam Yavari; Awat Feizi; Fahimeh Haghighatdoost; Azin Ghaffari; Hassan Rezvanian
Journal:  Endocrine       Date:  2020-10-15       Impact factor: 3.633

9.  Serum calcium levels and hypertension among U.S. adults.

Authors:  Charumathi Sabanayagam; Anoop Shankar
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-27       Impact factor: 3.738

10.  Evaluation of serum magnesium differences in hypertensive crises and control patients: A randomly matched case-control study.

Authors:  IfeanyiChukwu O Onor; Emily K Johnston; Nicole G Little; Lashira M Hill; Oluwabunmi E Lawal; Casey J Payne; Mallory R Coleman; Carolkim H Huynh; Sarah E Bilbe; Ahlam A Ayyad; Kabrea J Jones; Jasmine D Kinnard; Rosanna Dastoori; Devinn K Rolland; Amanda S Miller; Robbie A Beyl; Christopher J Gillard; John I Okogbaa; Daniel F Sarpong; Rim M Hadgu; Amne Borghol; Samuel C Okpechi; Mihran V Naljayan; Shane E Sanne; Shane G Guillory
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-08       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.